## **Core Concept**
The International Normalized Ratio (INR) is a laboratory test used to measure the effectiveness of blood clotting, particularly in patients undergoing anticoagulant therapy with warfarin. The goal of anticoagulation therapy is to prevent thrombosis while minimizing the risk of bleeding. The recommended INR level varies depending on the specific clinical indication for anticoagulation.

## **Why the Correct Answer is Right**
For most patients requiring anticoagulation, such as those with atrial fibrillation, pulmonary embolism, or deep vein thrombosis, the target INR range is between 2.0 and 3.0. This range provides an optimal balance between reducing the risk of thromboembolic events and minimizing the risk of bleeding complications. Achieving an INR within this range is associated with a reduced risk of both thrombosis and bleeding.

## **Why Each Wrong Option is Incorrect**
* **Option A:** An INR of 3.5 increases the risk of bleeding without providing additional protection against thrombosis.
* **Option D:** An INR >5.0 significantly increases the risk of bleeding and is generally considered too high for most patients, necessitating a reduction in anticoagulant dose or reversal of anticoagulation if bleeding occurs.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that regular INR monitoring is crucial for patients on warfarin to ensure that their INR levels remain within the therapeutic range. This helps in minimizing the risks associated with both under-anticoagulation (thrombosis) and over-anticoagulation (bleeding).

## **Correct Answer:** . 2-3